[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349829-105":59,"doc-detail-349829-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chondroitin-sulfate-e-activates-il-6stat3-signaling-to-drive-androgen-independent-growth-in-castration-resistant-prostate-cancer","Chondroitin sulfate E activates IL-6/STAT3 signaling to drive androgen-independent growth in castration-resistant prostate cancer","","Castration-resistant prostate cancer (CRPC) persists despite androgen receptor (AR) pathway inhibition, and the way distinct chondroitin sulfate (CS) sulfation motifs shape therapy resistance remains unclear. This study identifies the CS-E motif as a critical regulator of IL-6/STAT3 signaling and a driver of hormone-independent growth. Using RNA-seq, real-time PCR, flow cytometry, and a newly engineered CS-E–specific lectin (Cochlin B8), it shows androgen deprivation increases GALNAC4S-6ST and CS-E, enhancing IL-6 binding and sustained STAT3 activation, while genetic or pharmacological blockade reduces CS-E, IL-6 binding, and proliferation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chondroitin-sulfate-e-activates-il-6stat3-signaling-to-drive-androgen-independent-growth-in-castration-resistant-prostate-cancer/349829/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chondroitin-sulfate-e-activates-il-6stat3-signaling-to-drive-androgen-independent-growth-in-castration-resistant-prostate-cancer/349829.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does chondroitin sulfate E (CS-E) play in CRPC under androgen deprivation?","Question",{"text":112,"@type":113},"Androgen deprivation increases CS-E production on prostate cancer cells, where CS-E strengthens IL-6 binding and sustains IL-6/STAT3 signaling, enabling androgen-independent proliferation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study enable detection of CS-E?",{"text":117,"@type":113},"Because reliable CS-E detection tools were lacking, the researchers engineered a novel mutant lectin, Cochlin B8, with selective affinity for CS-E to monitor it on cancer cell surfaces.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens when CS-E biosynthesis is inhibited?",{"text":121,"@type":113},"Blocking GALNAC4S-6ST genetically or pharmacologically reduces CS-E levels, impairs IL-6 binding, attenuates STAT3 activation, and selectively suppresses proliferation under hormone-depleted conditions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349829,1790190928,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Ota etal. Cell Communication and Signaling (2026) 24:98  \n[https://doi.org/10.1186/s12964-026-02657-x](https://doi.org/10.1186/s12964-026-02657-x)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nChondroitin sulfate E activates IL-6/STAT3   signaling to drive androgen-independent growth in castration-resistant prostate cancer  \nHayato Ota1,3, Kazuo Yamamoto2 and Shoko Nishihara1,3*  \nAbstract  \nBackground Castration-resistant prostate cancer (CRPC) remains a major clinical challenge, as tumor growth persists despite androgen receptor (AR) pathway inhibition. Glycosaminoglycans, particularly chondroitin sulfate (CS), are increasingly recognized as modulators of oncogenic signaling. However, the contribution of distinct sulfation motifs to therapeutic resistance is poorly understood. Here, we identify the CS-E motif as a critical regulator of IL-6/STAT3 signaling and a driver of hormone-independent growth in CRPC.  \nMethods Transcriptomic profiling (RNA-seq), real-time PCR, and flow cytometry were employed to assess CS sulfation changes in C4-2 prostate cancer cells under androgen-deprived conditions. Because reliable tools to detect CS-E have been lacking, we engineered a novel mutant lectin (Cochlin B8) with selective affinity for CS-E.  \nThis innovation enabled precise monitoring and functional characterization of CS-E on the surface of cancer cells. Functional studies combined GALNAC4S-6ST knockdown, pharmacological inhibition with Chst15-IN-1, and signaling assays to examine effects on IL-6/STAT3 activation and cell proliferation.  \nResults Androgen deprivation induced upregulation of GALNAC4S-6STand enhanced CS-E biosynthesis on the cell surface. Elevated CS-E facilitated IL-6 binding to the cell surface, potentiated STAT3 phosphorylation, and sustained androgen-independent proliferation. Genetic or pharmacological inhibition of GALNAC4S-6ST significantly reduced CS-E levels, impaired IL-6 binding, attenuated STAT3 activation, and selectively suppressed proliferation under hormone-depleted conditions (IC₅₀ = 1.39 µM under androgen-deprived conditions vs. 4.46 µM under androgenreplete conditions) . These effects were specific to IL-6/STAT3, with no detectable impact on AR-independent EGFR or WNT signaling pathways.  \nConclusions This study reveals a previously unrecognized mechanism whereby CS-E sustains CRPC progression by selectively enhancing IL-6/STAT3 signaling when AR signaling is suppressed. Importantly, the development of Cochlin B8 overcomes a major technical barrier in CS-E research, providing a novel tool for its specific detection and functional analysis. Targeting CS-E biosynthesis represents a promising therapeutic strategy to counter resistance and improve prostate cancer treatment.  \n*Correspondence: Shoko Nishihara [shoko@soka.ac.jp](shoko@soka.ac.jp)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-","cbCaifmsNY8EU7Wq","https://ap.wps.com/l/cbCaifmsNY8EU7Wq","pdf",2272677,14,"English","# Abstract\n# Methods\n## Transcriptomic and cellular assays\n## CS-E detection tool\n## Functional inhibition and signaling readouts\n# Results\n# Conclusions\n# Plain English Summary\n# Keywords\n# Background","[{\"question\":\"What role does chondroitin sulfate E (CS-E) play in CRPC under androgen deprivation?\",\"answer\":\"Androgen deprivation increases CS-E production on prostate cancer cells, where CS-E strengthens IL-6 binding and sustains IL-6/STAT3 signaling, enabling androgen-independent proliferation.\"},{\"question\":\"How did the study enable detection of CS-E?\",\"answer\":\"Because reliable CS-E detection tools were lacking, the researchers engineered a novel mutant lectin, Cochlin B8, with selective affinity for CS-E to monitor it on cancer cell surfaces.\"},{\"question\":\"What happens when CS-E biosynthesis is inhibited?\",\"answer\":\"Blocking GALNAC4S-6ST genetically or pharmacologically reduces CS-E levels, impairs IL-6 binding, attenuates STAT3 activation, and selectively suppresses proliferation under hormone-depleted conditions.\"}]","Chondroitin sulfate E activates IL-6/STAT3 signaling to drive androgen-independent growth in castration-resistant prostate cancer | PDF",1790085842,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c903c2d440903f685cde4688c7c17c6.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e15917d115fc731b72d3915f5b302196.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc4ea8cccf55f130f787dfb5258769cf.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a980b9bec4d29142da2fe9c5d6b73a74.webp",980,1306]